Psychiatry & Mental Health Clinical Trials

Statistical methods in psychiatry & mental health trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All psychiatry & mental health trials

833 results

• ENACT-aMCIIndependent statistical analysis of ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 26NCT03711396
• ENCOREIndependent statistical analysis of Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 81NCT01455012
• ENGAGEIndependent statistical analysis of Engaging Patients in Tobacco Cessation Resources in Dental Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03656874).Phase NAResults postedn = 56NCT03656874
• ENGAGESIndependent statistical analysis of Electroencephalography Guidance of Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02241655).Phase NAResults postedn = 1,400NCT02241655
• Enhancing Adolescent Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Adolescent Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03249350).Phase NAResults postedn = 129NCT03249350
• Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01822587).Phase 2Results postedn = 181NCT01822587
• Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 192NCT01352637
• Environmental Treatment for Seasonal Affective Disorder (SAD): Complete Statistical AnalysisIndependent statistical analysis of Environmental Treatment for Seasonal Affective Disorder (SAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00139997).Phase NAResults postedn = 26NCT00139997
• ENVISIONIndependent statistical analysis of A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 1,027NCT05310071
• Epidemiology of Depression, Anxiety, and Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Epidemiology of Depression, Anxiety, and Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717041).Phase NAResults postedn = 1,206NCT00717041
• Epigenetic Regulation of BDNF in Major Depression: Complete Statistical AnalysisIndependent statistical analysis of Epigenetic Regulation of BDNF in Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182103).Phase NAResults postedn = 110NCT01182103
• EPOCHIndependent statistical analysis of An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2/3Results postedn = 2,211NCT01739348
• EQUATORIndependent statistical analysis of Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 524NCT01668797
• EQUIPED-ADRDIndependent statistical analysis of Enhanced Quality in Primary Care for Elders With Diabetes and Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 355NCT03723707
• EQUIPPEDIndependent statistical analysis of Efficiency And Quality In Post-Surgical Pain Therapy After Discharge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05221866).Phase NAResults postedn = 711NCT05221866
• ERECTIndependent statistical analysis of Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 56NCT00737893
• Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: Complete Statistical AnalysisIndependent statistical analysis of Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 103NCT02657317
• Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression: primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 361NCT01256177
• Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 120NCT07160439
• Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 252NCT00536198
• Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 20NCT03854019
• Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism: Complete Statistical AnalysisIndependent statistical analysis of Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00325572).Phase 1Results postedn = 89NCT00325572
• Evaluation of a Computerized Opioid Overdose Prevention Program: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Computerized Opioid Overdose Prevention Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02040077).Phase NAResults postedn = 75NCT02040077
• Evaluation of a Mental Health Physician Support Program in Nova Scotia: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Mental Health Physician Support Program in Nova Scotia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 285NCT01975948
• Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer: primary endpoint results, effect estimate with confidence…Phase NAResults postedn = 30NCT05932810
• Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 20NCT06717282
• Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 577NCT01143701
• Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617201).Phase 2Results postedn = 50NCT00617201
• Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05704543).Phase 4Results postedn = 132NCT05704543
• Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 80NCT04683835
• Evaluation of Doxazosin to Alter the Abuse of Oxycodone: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Doxazosin to Alter the Abuse of Oxycodone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03415581).Phase 2Results postedn = 13NCT03415581
• Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 4Results postedn = 355NCT00299702
• Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 104NCT00711100
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 310NCT03247517
• Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1Results postedn = 11NCT02614586
• Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of the Rectal Reflex Using Anal Acoustic Reflectometry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02782377).Phase NAResults postedn = 40NCT02782377
• EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).Phase 2/3Results postedn = 25NCT04210180
• EVarQuitIndependent statistical analysis of EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262662).Phase 3Results postedn = 320NCT03262662
• Exercise Training to Improve Cognitive Function: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training to Improve Cognitive Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03824639).Phase NAResults postedn = 60NCT03824639
• Expectation of Unpleasant Events in Anxiety Disorders: Complete Statistical AnalysisIndependent statistical analysis of Expectation of Unpleasant Events in Anxiety Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00055224).Phase NAResults postedn = 921NCT00055224
• ExpeditionPROIndependent statistical analysis of A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 26NCT02760602
• Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 7NCT03638466
• Exploratory Study for Toivoa-001 on Human Factors: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study for Toivoa-001 on Human Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06477913).Phase NAResults postedn = 13NCT06477913
• Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 239NCT00595231
• Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01122849).Phase 2Results postedn = 61NCT01122849
• Exploring the Effects of Corticosteroids on the Human Hippocampus: Complete Statistical AnalysisIndependent statistical analysis of Exploring the Effects of Corticosteroids on the Human Hippocampus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03896659).Phase 4Results postedn = 66NCT03896659
• Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: Complete Statistical AnalysisIndependent statistical analysis of Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 50NCT02445339
• eXtRaIndependent statistical analysis of Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia: primary endpoint results, effect estimate with confidence interval,…Phase 4Results postedn = 75NCT01213836
• Faith-Based Toolbox for African Americans With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Faith-Based Toolbox for African Americans With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04325204).Phase NAResults postedn = 54NCT04325204
• Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder: Complete Statistical AnalysisIndependent statistical analysis of Family-Based Interoceptive Exposure for Avoidant Restrictive Food Intake Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06110806).Phase NAResults postedn = 12NCT06110806

← All therapeutic areas